Six peptide myths

The six myths are claims that circulate on social media, clinic blogs and supplier pages, and every one of them is testable. The table sets each against what the primary sources report.

The myths share one habit. They talk about "peptides" as if the word named one substance. Every useful answer below names a compound, a study model and a source.

Peptides and anabolic steroids belong to different chemical classes. The US National Library of Medicine's MeSH vocabulary defines peptides as compounds made of amino acids joined by peptide bonds into linear, branched or cyclical structures. ^[1] It defines steroids by a shared nucleus: a fused, reduced 17-carbon ring system. ^[2] Anabolic androgenic steroids are synthetic variations of the male sex hormone testosterone. ^[11]

The size gap is large. Testosterone has the formula C19H28O2 and a molecular weight of 288.4. ^[4] BPC-157 has the formula C62H98N16O22 and a molecular weight of 1419.5, almost five times heavier. ^[3] One is a compact ring-based molecule. The other is a 15-residue chain of amino acids.

The confusion has a real source. Both groups appear on the WADA 2026 Prohibited List and both are prohibited at all times. Anabolic androgenic steroids sit in class S1 (anabolic agents). Peptide hormones and growth factors sit in class S2, and BPC-157 is named in class S0 (non-approved substances). ^[12] Enforcement also lumps them together. In August 2026 the TGA and NSW Police seized more than $120,000 of "illicit peptide and anabolic steroid products" from 2 residential premises. ^[13]

Separate chemistry means separate evidence. A finding about testosterone tells you nothing about BPC-157, and the reverse holds too.

Peptide research reaches far beyond muscle and sport. The TGA lists approved peptide-based medicines that include insulin and insulin analogues, GLP-1 receptor agonists such as semaglutide, oxytocin, desmopressin and octreotide. ^[9] Each is tested in human trials before approval.

The trial record shows the range:

• Obstetrics. A 2019 Cochrane review of prophylactic oxytocin in the third stage of labour included 24 trials, with 23 trials and 10,018 women contributing data. ^[14]
• Infectious disease. A randomised trial in Japan assigned 316 patients with chronic hepatitis B to two thymosin alpha-1 groups and followed them for 72 weeks. ^[15]
• Rare genetic disease. A crossover trial of elamipretide, a mitochondrial tetrapeptide that interacts with cardiolipin, randomised 12 people with Barth syndrome. Neither primary endpoint was met in the blinded first part. ^[16]

Sport is where many readers first meet the word. The WADA List is also where the regulatory stakes are sharpest for athletes, because peptide classes S0 and S2 are prohibited in and out of competition. ^[12]

Peptides differ in length, target and origin, so a claim about "peptides" as a group carries almost no information. MeSH calls chains of about 2 to 12 amino acids oligopeptides and chains of about 13 or more polypeptides, with proteins as larger versions again. ^[1]

We checked every compound in our range against PubChem, PubMed, the June 2026 Poisons Standard and the WADA 2026 List on 29 September 2026. The spread inside one catalogue looks like this:

Two lessons follow. The receptors differ, so the research questions differ. And some products sold in the peptide category are not peptides at all.

Even close relatives need separate reading. BPC-157 and TB-500 are often sold together, yet one is a 15-residue gastric peptide fragment and the other a 7-residue piece of thymosin beta-4. Our comparison of BPC-157 and TB-500 sets their structures and literature side by side, and both sit in our recovery research peptides range.

How long a peptide lasts in the body is a property of its structure, and published half-lives run from minutes to days. "Instant" and "slow" describe no peptide in general.

The long-lived molecules were engineered that way. Semaglutide's developers added two amino acid substitutions and a fatty acid chain to increase albumin binding and resist metabolic breakdown. ^[18] CJC-1295's authors describe native GHRH as limited by its short duration of action, which the analogue was built to extend. ^[6]

BPC-157 sits at the other end. In the 2022 rat and dog study it was rapidly broken down into small peptide fragments and then single amino acids. ^[17] A half-life is a pharmacokinetic measurement. It tells you how long the molecule stays measurable, and on its own it predicts no outcome in a person.

"Natural" describes where a molecule comes from and predicts nothing about harm. Many research peptides are also synthetic. A 2025 review describes BPC-157 as a synthetic pentadecapeptide originally isolated from gastric juice. ^[8] TB-500 and melanotan II are synthetic fragments and analogues, as the table above shows.

Natural hormones carry adverse events too. A systematic review of randomised trials gave growth hormone to 220 healthy older adults. Those receiving it were more likely to experience soft tissue oedema, joint pain, carpal tunnel syndrome and gynaecomastia, and somewhat more likely to develop diabetes or impaired fasting glucose. ^[19] Oxytocin, another hormone the body makes, is listed in Schedule 4 of the Poisons Standard. ^[10]

Regulators and researchers have also recorded harms linked to unapproved products:

• Regulator reports. Reports received by the TGA and state hospital data identify serious adverse effects associated with unapproved peptides, including liver damage and severe allergic reactions requiring hospitalisation. ^[20]
• A cluster in Victoria. The ABC reported in August 2026 that seven Victorian patients had been hospitalised for acute liver toxicity after using a counterfeit product sold as retatrutide. A treating specialist called a contaminated batch one possible explanation, with no test results yet to support it. ^[21]
• Case reports. A 2012 dermatology report described melanoma in situ in a person using unlicensed melanotan. ^[22] A single case report cannot establish cause or frequency.

Content and purity fail too. A 2024 study bought 3 vials of semaglutide from illegal online pharmacies. Measured content exceeded the label by 28.56% to 38.69%, purity measured 7.7% to 14.37% against 99% claimed, and endotoxin was found in every sample. ^[23] The Alcohol and Drug Foundation reports that Australian testing of three products sold as retatrutide found peptide content from around half to almost double the labelled amount. ^[24][25]

For BPC-157 specifically, the human record is too small to characterise adverse events either way. The published pilots enrolled 12 women with interstitial cystitis and 2 adults in an intravenous infusion study, with no control groups. ^[26][27] A 2019 review found most studies were in small rodent models and that only a handful of research groups had studied the peptide in depth. ^[7] Our BPC-157 research overview covers that literature study by study.

No. The TGA states that disclaimers such as "research use only" or "not for human use" do not change whether a product is regulated as a therapeutic good, and do not remove advertising, manufacture, import, export or supply obligations. ^[9] Its safety alert on unapproved peptide products adds that such disclaimers do not make supply lawful or permit importation. ^[28]

Scheduling applies compound by compound. BPC-157 is listed in Schedule 4 (prescription only) of the June 2026 Poisons Standard, which commenced on 1 June 2026. It is also listed in Appendix D clause 5, which makes possession without authority an offence. ^[10] The TGA names BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 as examples of unapproved peptide products. ^[28] In sport, WADA names BPC-157 in class S0. ^[12]

Peptides Collective sells compounds for laboratory research use only. That phrase states the intended use of the sale. The law still applies to the compound itself, and our guide to Australian peptide law and the Poisons Standard sets out the status of every compound we stock.

Run four checks on any claim, from any seller, including us.

1. Name the compound. A claim about "peptides" in general cannot be checked. Ask which molecule, and find its PubChem record for the formula and molar mass.
2. Find the study and its model. Look for a PMID. Read who was studied: cells, rats, a pilot of 2 people or a trial of thousands. The table in the half-life section above is the pattern to follow.
3. Check the law and the sport list. Search the June 2026 Poisons Standard text for the compound and any # mark, then check the current WADA List.
4. Check the vial. Match the batch number on the label to a certificate for that batch.

The fourth check is where we do the work. Every batch we sell is tested by an independent lab before sale, for purity by HPLC and identity by mass spectrometry. The certificate is published under the batch number printed on the vial, and you can search it in our certificate of analysis library. Our testing page describes the process, and the guide on how to read a peptide certificate of analysis explains the HPLC trace and the mass spectrum.

A worked example: the identity result on a BPC-157 certificate should match a molar mass of about 1419.5 g/mol, the PubChem value for the 15-residue sequence. ^[3] The BPC-157 5mg product page links the certificate for the current batch.

Each of the six myths lumps every peptide together as one thing, and each falls apart once you name the compound, the study model and the source. Peptides and steroids differ in chemistry, half-lives differ by structure, and "natural" and "research use only" settle nothing about harm or legality. A batch certificate settles what is in one vial, and the Poisons Standard, the TGA and the WADA List settle the rest.